JP2022513152A5 - - Google Patents

Info

Publication number
JP2022513152A5
JP2022513152A5 JP2021530284A JP2021530284A JP2022513152A5 JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5 JP 2021530284 A JP2021530284 A JP 2021530284A JP 2021530284 A JP2021530284 A JP 2021530284A JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5
Authority
JP
Japan
Prior art keywords
mypop
cancer
seq
myb
transcription factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021530284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513152A (ja
JP7642538B2 (ja
Filing date
Publication date
Priority claimed from US16/206,526 external-priority patent/US20200174016A1/en
Application filed filed Critical
Publication of JP2022513152A publication Critical patent/JP2022513152A/ja
Publication of JP2022513152A5 publication Critical patent/JP2022513152A5/ja
Application granted granted Critical
Publication of JP7642538B2 publication Critical patent/JP7642538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021530284A 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのＭｙｂ関連転写因子（ＭＹＰＯＰ） Active JP7642538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/206,526 US20200174016A1 (en) 2018-11-30 2018-11-30 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy
US16/206,526 2018-11-30
PCT/EP2019/082845 WO2020109439A1 (en) 2018-11-30 2019-11-28 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy

Publications (3)

Publication Number Publication Date
JP2022513152A JP2022513152A (ja) 2022-02-07
JP2022513152A5 true JP2022513152A5 (https=) 2023-01-11
JP7642538B2 JP7642538B2 (ja) 2025-03-10

Family

ID=68848224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530284A Active JP7642538B2 (ja) 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのＭｙｂ関連転写因子（ＭＹＰＯＰ）

Country Status (5)

Country Link
US (2) US20200174016A1 (https=)
EP (1) EP3887550A1 (https=)
JP (1) JP7642538B2 (https=)
CA (1) CA3121047A1 (https=)
WO (1) WO2020109439A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014519340A (ja) * 2011-06-16 2014-08-14 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． バイオマーカー組成物および方法

Similar Documents

Publication Publication Date Title
US7507532B2 (en) Cancer specific gene MH15
WO2014017491A1 (ja) Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子
JPWO2014007369A1 (ja) Ｆｇｆｒ２融合遺伝子
CN101246169B (zh) 口腔鳞癌诊断试剂、试剂盒及防治药物
KR20080114683A (ko) 질병에 대한 바이오마커로서의 지방생성 아데노바이러스
CN113667748A (zh) circIKBKB的抑制剂及其检测试剂在乳腺癌骨转移诊断、治疗和预后试剂盒的应用
JP2023123748A (ja) 転移性癌の診断及び治療の方法
CN109022461B (zh) 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用
CN101768214B (zh) 一种人肿瘤标志物-Tim17多肽及其用途
US20160267244A1 (en) Methods of predicting cancer lethality using replikin counts
WO2009116860A1 (en) Markers providing prognosis of metastasis among cancer patients
CN111139299B (zh) Josd2蛋白在制备治疗恶性肿瘤药物中的应用
JP2022513152A5 (https=)
EP2320932B1 (en) Methods of predicting cancer lethality using replikin counts
CN113528667B (zh) 一种骨巨细胞瘤的诊断方法
JP5316749B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット
EP1905780B1 (en) Cancer suppressing agent
CN107723369B (zh) Setd1b蛋白及其编码基因在肝癌诊断治疗中的应用
CN109022462B (zh) 一种PTEN基因的上游开放阅读框31aa-uORF核苷酸及其编码的多肽的应用
CN112661826A (zh) 小肽ERpeptide及其在急性髓系白血病中的应用
WO2021043340A2 (zh) 一种肿瘤标志物aquaporin 2蛋白及其应用
JP6839707B2 (ja) Ｇｐｒ１６０を過剰発現する癌の予防、診断および治療
JP5622156B2 (ja) シスプラチン耐性遺伝子診断方法及びシスプラチン治療効果遺伝子診断キット
EP2708606A1 (en) Novel biomarkers for human cervical cancer and/or HPV infection
CN121059800A (zh) Dhcr24与宫颈癌诊断、治疗、预后相关的用途